What is the difference between Chonluten and Thymalin?

Chonluten: Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration Thymalin: Thymic peptide bioregulator; restores thymic function and T-cell production; modulates cytokine balance; shown to extend lifespan in animal models

Is Chonluten FDA approved?

Chonluten is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Thymalin FDA approved?

Thymalin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Chonluten administered in research settings?

In research settings, Chonluten is typically administered via the oral or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Thymalin administered in research settings?

In research settings, Thymalin is typically administered via the subcutaneous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Chonluten vs Thymalin

Peptide Comparison

Chonluten vs Thymalin

Name: Chonluten vs Thymalin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Immune & Thymic peptides.

Chonluten

Bronchogen

RecoveryNot EvaluatedResearch Only

Half-life: Unknown

2 providers listed

Full Chonluten profile →

Thymalin

Thymus peptide

LongevityNot EvaluatedResearch Only

Half-life: Unknown

11 providers listed

Full Thymalin profile →

Bottom line

Thymalin carries stronger published evidence (RCT, 2 key studies) than Chonluten (Review, 2); both are research compounds.

Quick Verdict

Chonluten

Evidence

Review-level

Thymalin

Evidence

Emerging Clinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Thymalin
Oral administration option	Chonluten
Lower typical price per mg	Chonluten
More provider options (2 vs 11)	Thymalin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Chonluten

Thymalin

Mechanism Family

Immune & Thymic

Half-life

Unknown

FDA Status

not evaluated

Admin Routes

oral, subcutaneous

subcutaneous, intramuscular

Availability

Research Only

Providers

2 listed

11 listed

Avail. Notes

Russian peptide bioregulator (Glu-Asp-Lys) from Khavinson Institute. Developed for lung health. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical in US.

Russian thymic peptide bioregulator (Khavinson Institute). Distinct from Thymosin Alpha-1. Not FDA-approved. Not on any FDA list. Research chemical in US.

Research Evidence

Chonluten

Review-levelReview · 2 key studies · most recent 2022

Thymalin

Emerging ClinicalRCT · 2 key studies · dated evidence base — most recent 2003

Research Citations

Chonluten

Review2022 · International Journal of Molecular Sciences

Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers

Review2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Thymalin

RCT2003 · Neuroendocrinology Letters

Thymalin and epithalamin increase the lifespan of elderly people

Review2002 · Advances in Gerontology

Peptide bioregulators and melatonin inhibit the development of age-related pathologies

About Chonluten

Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration

Research Areas

bronchial repairlung tissue regenerationrespiratory anti-inflammatory

About Thymalin

Thymic peptide bioregulator; restores thymic function and T-cell production; modulates cytokine balance; shown to extend lifespan in animal models

Research Areas

immune restorationthymus function supportanti-agingimmune modulation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Chonluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Thymalin

Reported (Unverified — Pending Clinical Review)

autoimmune disease (use with caution)organ transplant (immunosuppression)

No established clinical contraindications

Price (per mg)

Chonluten

$2.70/mg

$2.00 – $3.10 range

8 vendors

View price index →Find providers →

Thymalin

$5.05/mg

$4.65 – $6.04 range

8 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Chonluten

2 listed

Browse directory →

Providers offering

Thymalin

11 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Immune & Thymic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Chonluten vs Thymalin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/chonluten/thymalin

https://peptidebase.io/peptides/compare/chonluten/thymalin Methodology License Download JSON Download CSV